Call for companies: Merck Millipore Seeking to Meet Biotech Companies & ResearchersNov. 19-24, 2017
* Priority for IATI members *
We are pleased to inform you that Merck Millipore Contract Development Organization (CDMO), which provides Bio-development services, plans to visit in Israel between November 19th to 24th, 2017.
This call is for small Biotech companies, start-ups or academic research groups that would like to participate in the upcoming event or to schedule a F2F meeting with Merck representatives.
The Merck Biodevelopment Services has 3 different sites, Martillac near Bordeaux FrancecGMP manufacturing facility, Boston USA and Shanghai with the aim to support Biotech start-ups transitioning from late research to early clinical phase including GMP manufacturing Phase 1-2-3 with the possibility to go up to commercial.
No royalties neither as upfront payment.
No IP kept and no proprietary technology used during process development.
No booking fee for slot.
Total freedom to operate.
The areas of activity:
USP, DSP to drug product
Cell line generation, Media, and feed selection, Clone selection, Cell line adaptation, Bank generation, Bank storage, Upstream definition.
Chromatography media screening, Viral inactivation/filtration step design, Sterile filtration optimization, TFF step design, Precipitation step design, Single-use implementation.
For more information, please contact Inbar Yacoby at Inbar@iati.co.il